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Conclusions: These data suggest: (1) persistent ‘minor’ pN2-disease 
following induction chemotherapy does not always exclude favourable 
outcome after surgery; (2) serial FDG-PET is able to select surgical 
candidates amongst patients with persistent ‘minor’ pN2-disease or 
with mediastinal clearance; (3) persistent ‘major’ pN2-disease has a 
poor prognosis and should not be considered for surgery.
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Prognostic significance of AJCC T2 descriptor-visceral pleura 
invasion, hilar atelectasis or obstructive pneumonitis for stage IB 
non-small-cell lung cancer (NSCLC) is dependent on tumor size
Ou, Sai-Hong I.1 Zell, Jason A.1 Ziogas, Argyrios2 Anton-Culver, Hoda2 
1 Chao Family Comprehensive Cancer Center, Orange, CA, USA 2 
Genetic Epidemiology Research Institute, Irvine, CA, USA 
Background: The T2 descriptor in the AJCC staging for non-small-
cell lung cancer (NSCLC) contains several non-size based criteria in 
addition to the criterion of tumor size greater than 3 cm. It remains un-
known if there are survival differences between patients whose tumors 
were staged according to these non-size based criteria when compared 
to patients whose tumors were staged according to tumor size.
Methods: We analyzed 10,545 stage IB NSCLC patients from the Cali-
fornia Cancer Registry (CCR) from 1989 to 2003. These patients were 
staged as IB disease according to three non-overlapping main criteria: 
1) tumor size [T2S]; 2) visceral pleura invasion, hilar atelectasis or 
obstructive pneumonitis [T2P]; 3) main bronchus involvement ≥ 2 cm 
from the carina [T2C]. Univariate survival analyses were conducted 
using the Kaplan-Meier method. Multivariate survival analyses were 
performed using Cox proportional hazards ratios.
Results: 5385 (51.1%) IB patients were staged according to tumor size 
[T2S], 4557 (43.2%) patients were staged by visceral pleura invasion, 
hilar atelectasis or obstructive pneumonitis [T2P] and 603 (5.7%) 
patients were staged by main bronchus involvement ≥ 2 cm from the 
carina [T2C]. 35.7% of the IB patients due to visceral pleura invasion, 
hilar atelectasis or obstructive pneumonitis [T2P] and 29.7% of the pa-
tients due to main bronchus involvement ≥ 2 cm from the carina [T2C] 
had tumors 3 cm or smaller. There was statistical significant difference 
in the 5-year survivorship and median overall survival (OS) among the 
3 types of stage IB NSCLC patients: (T2C: 38.6% and 39 months; T2P: 
38.0% and 38 months; T2C: 40.3% and 39 months; P = 0.0031). The 
5-year survival and median OS of these IB patients with tumor 3 cm or 
smaller were 53.3% and 67 months for T2P and 52.6% and 73 months 
for T2C respectively, similar to the 53.2% 5-year survival and 67 
months of median OS for stage IA patients. Cox proportional hazards 
model revealed that T2P > 3 cm is a poor prognostic factor (vs. T2S, 
Hazard Ratio [HR] = 1.13, 95% Confidence Interval (CI) = 1.06-1.20) 
while T2P ≤ 3 cm was a favorable prognostic factor (vs. T2S, HR = 
0.87, 95% CI = 0.80-0.95). T2C > 3 cm (vs. T2S, HR = 0.98, 95% CI = 
0.84-1.13) and T2C ≤ 3 cm (vs. T2S, HR = 0.86, 95% CI = 0.69-1.08) 
were not independent poor prognostic factors.
Conclusions: Non-size based T2 descriptors-visceral pleura inva-
sion, hilar atelectasis or obstructive pneumonitis are poor independent 
prognostic factors when the tumor size was greater than 3 cm. Stage IB 
NSCLC patients staged by non-size based criteria T2 descriptors whose 
tumors were 3 cm or smaller had survival similar to stage IA NSCLC 
patients. Future proposed changes to the AJCC T2 descriptor, the 
non-size based criteria should be linked to size criteria rather than as 
independent criteria. The prognostic signiﬁcance of the T2C criterion 
requries further studies.
Cox proportional hazards model showing prognostic signiﬁcance of 
various AJCC T2 descrpitors.
T2 descriptor
Number of 
patients
Hazard ratio
95% Conﬁdence 
interval
P-value
T2S 5385 1.00   
T2P > 3 cm 2960 1.127 (1.056-1.202) 0.0003
T2P ≤ 3 cm 1597 0.869 (0.796-0.948) 0.0016
T2C > 3 cm 424 0.975 (0.841-1.130) 0.7343
T2C ≤ 3 cm 179 0.863 (0.693-1.075) 0.1895
 
Adjustment included: age at diagnosis, gender, race, socioeconomic 
status, marital status, histology, histologic grade, tumor lobar location, 
surgical treatment, chemotherapy and radiation.
T2S-T2 descriptor: by size only
T2P-T2 descriptor: visceral pleura invasion, hilar atelectasis or obstruc-
tive pneumonitis
T2C-T2 descriptor: main bronchus involvement ≥ 2 cm from carina
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Preliminary experience with mediastinal staging of patients with 
non-small cell lung cancer using endobronchial ultrasound (EBUS/
TBNA)
Jørgensen, Ole D.; Ømark, Henrik; Eckardt Jens; Olsen, Karen E. 
Odense University Hospital, Odense, Denmark
Background: Treatment and prognosis of patients with non-small 
cell lung cancer depend on the stage of the disease at the time of the 
diagnosis. Mediastinoscopy has been the golden standard for staging of 
the mediastinum for many years, and it has been proven that the false 
negative rate of N2-disease by this procedure is near 20% or more. The 
consequence of this is often a futile thoracotomy without beneﬁt for the 
patient. 
We would like to report the results of our preliminary experience with 
EBUS/TBNA for staging of the mediastinum. 
Methods: A total of 152 consecutive patients were examined by 
EBUS/TBNA during the ﬁrst year (2006) the method was used in our 
department. The indication was mediastinal staging in 82 patients 
(53.9%). The remaining 70 patients were examined because of an 
undiagnosed mediastinal mass, follow-up after resection of NSCLC, or 
restaging after chemotherapy. The 3 examiners had no previous experi-
ence with endoscopic ultrasound, but were trained for a period of 2 
days in another institution with experience in the method. 
The examinations of the 82 patients were carried out in general an-
aesthesia with a linear scanner (BF-UC160F, Olympus). Cytological 
samples were taken by 22G needle aspiration (NA-201SX-4022, Olym-
pus) from all lymph node stations visualized. Patients positive for N2 
or N3-disease (n=32) by EBUS/TBNA were not examined further, but 
referred to oncological treatment. Patients without N2 or N3-disease 
